SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000912057-00-009765
Filing Date
2000-03-03
Accepted
2000-03-03 00:00:00
Documents
9
Period of Report
1999-12-31

Document Format Files

Seq Description Document Type Size
1 10-K 10-K 245345
2 EX 10.1 EX-10.1 17690
3 EX 10.2 EX-10.2 39683
4 EX 10.3 EX-10.3 41338
5 EX 10.27 TAISHO AGREEMENT EX-10.27 189593
6 EX 10.28 FLEET CREDIT AGT EX-10.28 218060
7 EX 21 EX-21 238
8 EX 23 - CONSENT OF INDEPENDENT ACCOUNTANTS EX-23 634
9 EX 27 - FINANCIAL DATA SCHEDULE EX-27 2380
  Complete submission text file 0000912057-00-009765.txt   757031
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19319 | Film No.: 561256
SIC: 2834 Pharmaceutical Preparations